MCM
BLFS icon

MAI Capital Management’s BioLife Solutions BLFS Stock Holding History

MAI Capital Management’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-145
Closed -$2.77K – 2401
2026
Q1 		$2.77K Buy
145
+76
+110% +$1.68K ﹤0.01% 3797
2025
Q4 		$1.67K Hold
69
– – ﹤0.01% 3472
2025
Q3 		$1.76K Hold
69
– – ﹤0.01% 3337
2025
Q2 		$1.49K Buy
+69
New +$1.55K ﹤0.01% 3504
2017
Q1 		– Sell
-14,881
Closed -$24K – 455
2016
Q4 		$24K Buy
+14,881
New +$24K ﹤0.01% 439

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

MAI Capital Management's BLFS Position: Q2 2026 in Review

MAI Capital Management sold out of BioLife Solutions (BLFS) in Q2 2026, closing a stake of 145 shares — an estimated $2.77K sold.

MAI Capital Management first reported a position in BLFS in Q4 2016 and held it in 5 quarters. The position peaked at $24K in Q4 2016. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • MAI Capital Management reported no remaining BioLife Solutions position as of Q2 2026 after selling out during the quarter.
  • MAI Capital Management sold 145 BioLife Solutions shares in Q2 2026, an estimated $2.77K.
  • MAI Capital Management first reported a position in BioLife Solutions in Q4 2016 and held it in 5 quarters.
  • MAI Capital Management's BioLife Solutions position peaked at $24K in Q4 2016.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.